DNA 정제 없이 전혈을 사용한 빠른 ABO 유전형 검사
Background : ABO genotyping is commonly used in cases of an ABO discrepancy between cell typing and serum typing, as well as in forensic practice for personal identification and paternity testing. We evaluated ABO genotyping via multiplex allele-specific PCR (ASPCR) amplification using whole blood samples without DNA purification.
Methods : A four-reaction multiplex ASPCR genotyping assay was designed to detect specific nucleotide sequence differences between the six ABO alleles A101, A102, B101, O01, O02, and cis-AB01. The ABO genotypes of 127 randomly chosen samples were determined using the new multiplex ASPCR method.
Results : The genotypes of the 127 samples were found to be A101/A102 (n=1), A102/A102 (n=9), A101/O01 (n=3), A102/O01 (n=12), A102/O02 (n=14), B101/B101 (n=5), B101/O01 (n=18), B101/ O02 (n=15), O01/O01 (n=14), O02/O02 (n=8), O01/O02 (n=14) and A102/B101 (n=14), from which phenotypes were calculated to be A (n=39), B (n=38), O (n=36) and AB (n=14). The multiplex AS-PCR assay results were compared with the serologically determined blood group phenotypes and genotypes determined by DNA sequencing, and there were no discrepancies.
Conclusions : This convenient multiplex ASPCR assay, performed using whole blood samples, provides a supplement to routine serological ABO typing and might also be useful in other genotyping applications. There are several polymerase chain reaction (PCR) based methods used to identify the ABO genotypes, such as PCR followed by restriction digestion [3, 4] , denaturing gradient gel electrophoresis [5] , single-strand conformation polymorphism [6] , and allele-specific PCR [7, 8] . Although PCR is technically simple, it is labor-intensive and time-consuming. The rate-limiting step is usually the extraction of DNA from whole blood samples. A rapid and simple method for ABO genotyping is needed due to the importance of speed in practical ABO genotyping.
Multiplex allele-specific PCR (ASPCR) technology is able to meet these criteria for its advantages in cost, reaction time, and simplicity of handling. Furthermore, the technique has been successfully used for genotyping in various human mutations [9] [10] [11] . Therefore, multiplex ASPCR represents an alternative to current standard ABO genotyping protocols as PCR followed by restriction digestion or sequencing.
However, to take full advantage of the potentiality of multiplex ASPCR and to accelerate the entire analytical procedure, a simple, rapid and cost-saving method to prepare DNA from a high number of clinical blood samples is also needed. This paper reports a rapid and simple method for ABO genotyping via multiplex ASPCR amplification using whole blood as the DNA source. For DNA sequencing, a 2,051 bp fragment spanning exons 6 and 7, and intron 6 was amplified using the primer pair ABOe6F1 (5 ′ -TGCAGTAGGAAGGATGTGCTCG TG-3′ ) and ABOi7R4 (5 ′ -ACAACAGGACGGACAAAGGAAACAG-3′ ) as described previously [12] . PCR products were electrophoresed in agarose gel and purified using Qiaquik gel extraction kit 
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(n=14), O02/O02 (n=8), O01/O02 (n=14) and A102/B101 (n=14).
Methods
1) Primer design
The design of the oligonucleotide primers was based on the nucleotide sequence of the ABO gene [2] . In order to meet the requirement that nucleotide substitutions are clearly related to specific phenotypes, this study focused on the nucleotide positions 261, 297, 467, and 803, so as to discriminate between the A101, A102, B101, O01, O02, and cis-AB01 alleles, as shown in Fig 1 . Table 1 shows the oligonucleotide primer sequences, their combinations, amplification product lengths, and allele specificities. The 3'base of each primer (except int6) was designed to correspond to the nucleotides at positions 261, 297, 467, and 803, which define the polymorphisms. Primer int6 is a common primer and its sequence is located in intron 6. Allele specificity was further enhanced by introducing additional deliberate mismatches to the oligonucleotide primer sequences at position -2
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from the 3'-terminus. An internal control template and primers were used to confirm the reliability and reproducibility of each assay. In each PCR reaction, control bacteriophage Lamda genomic DNA template and control primers (forward, 5 ′ -gat gag ttc gtg tcc gta caa ctg g-3 ′ ; reverse, 5′ -ggt tat cga aat cag cca ca-3 ′ ) were used to amplify a 500 bp PCR fragment, which corresponded to nucleotides 7,131-7,630 of the Lambda genome and served as a positive amplification control [13] .
2) PCR reactions
PCR
RESULTS
Our multiplex ASPCR assay contains four independent PCR reactions ( Table 1 ). In the first reaction, the 261G-int6
primer pair was selected to amplify the 205 bp fragment in order to detect the A101, A102, B101, and cis-AB01 alleles, and the 467C-803G primer pair was selected to amplify the 381 bp fragment to detect the A101, O01, and O02
alleles. In the second reaction, the 297A-int6 primer pair
The primers are named based on the position of their 3' end relative to the cDNA sequence of A101 allele. 
cis-AB01 . Nucleotides at these positions were detected in PCR reactions using the appropriate primers as shown with arrows (given in Table 1 ).
was selected to amplify the 164 bp fragment to detect the A101, A102, O01, and cis-AB01 alleles, and the 467C-803C
primer pair was selected to amplify the 381 bp fragment to detect the B101 allele. In the third reaction, the 261A-int6
primer pair was selected to amplify the 205 bp product to detect the O01 and O02 alleles, and the 467T-803G primer pair was selected to amplify the 381 bp product to detect the A102 allele. In the fourth reaction, the 297G-int6 primer pair was selected to amplify the 164 bp product to detect the B101 and O02 alleles, and the 467T-803C primer pair was selected to amplify the 381 bp product to detect the cis-AB01 allele.
Random mating, with the six different alleles at the ABO locus, can result in 21 different genotype combinations, which are all detectable using the developed method. However, only 12 different genotype combinations were detected from the 127 randomly chosen samples (Fig. 2) . The A101/A101, A101/O02 and A101/B101 genotypes and the cis-AB01 containing genotypes could not be detected. This observation is not unexpected given the frequency of these alleles and the size of the study group. In order to test the specificity of the cis-AB01 allele specific primer pair (467T-803C), we include a cis-AB blood sample in our test, and the genotype was identified as cis-AB01/O02. Fig. 2 shows the agarose gel electrophoresis patterns for the 13 genotypes.
With our multiplex ASPCR assay, the genotypes of the 127 samples were found to be A101/A102 (n=1), A102/A102 (n=9), A101/O01 (n=3), A102/O01 (n=12), A102/O02 (n=14), B101/B101 (n=5), B101/O01 (n=18), B101/O02 (n=15), O01/O01 (n=14), O02/O02 (n=8), O01/O02 (n=14), and A102/B101 (n=14), from which phenotypes were calculated to be A (n=39), B (n=38), O (n=36), and AB (n=14). The multiplex ASPCR assay results were compared with the serologically determined blood group phenotypes and genotypes determined by DNA sequencing, and there were no discrepancies. These results demonstrated that the ASPCR method described here is reliable and accurate.
DISCUSSION
PCRs using allele-specific primers is a powerful tool for discriminating between alleles arising from single base substitutions or deletions without the necessity of post-amplification restriction endonuclease digestion or hybridization.
The allele discrimination in ASPCR is based on the inability of Taq DNA polymerase, which lacks the 3 ′ -exonucleolytic proofreading activity, to extend a primer when the 3' nucleotide is not complementary to a DNA template.
ASPCR with unmodified, mutation-specific primers is commonly used to detect mutations. However, such primers may yield false-positive amplifications, even under optimized conditions. Such false-positive results are unaccept- significant drawback of the ASPCR assay is that mutationspecific primers introduce the mutation of interest into the amplified product. Thus, it is not possible to confirm a positive result by direct DNA sequencing of the amplicon.
A multiplex ASPCR assay containing four independent PCR reactions was developed for direct genotyping of the A101, A102, B101, O01, O02, and cis-AB01 alleles (Table 1) .
Proper design of the primer DNA sequences is important for efficient detection in ASPCR because unexpected primer extension with mismatch-forming DNA primers can occur when PCR is carried out under unsuitable reaction conditions with regard to the amplification cycle, reaction time and temperature. An extra destabilizing mismatch was reported to increase the specificity of ASPCR [14] . Therefore, allele-specific primers were designed to make the 3' end nucleotide specific to the nucleotides at positions 261, 297, 467, and 803, which discriminate between the A101, A102, B101, O01, O02, and cis-AB01 alleles (Fig. 1) . In addition, the 2nd nucleotide from the 3' end was mismatched with the template DNA.
Using the multiplex ASPCR assay, we could accurately genotype 127 blood samples. However, we could not detect genotypes A101/A101, A101/O02, and A101/B101 and the cis-AB01 containing genotypes due to the low frequency of these alleles. Song et al. genotyped 222 samples and reported the ABO genotype frequencies of A101/A101, A101/O02, and A101/ B101 to be 0.00%, 1.35%, and 0.45%, respectively [15] . Also, the cis-AB blood group is rare and the overall frequency of this blood group was determined to be 0.0354% among southwestern Korean blood donors [16] .
The multiplex ASPCR assay was performed directly using whole blood samples without DNA purification. This was successfully carried out using the AnyDirect solution, which has been used to amplify target DNA fragments directly from whole blood [17] , plant tissue [18] and human feces [19] without the need for DNA extraction. AnyDirect solution is a new PCR reaction buffer that conserves the enzyme activity of DNA polymerases for effective use in direct PCR from whole blood, which contains PCR inhibitors [17] . AnyDirect solution is primarily composed of zwitterionic buffer and PCR amplification facilitators that suppress PCR inhibitors in whole blood. In our assay, a small aliquot (1.5 μ L) of whole blood was added directly to a PCR mix containing AnyDirect solution and then subjected to PCR. The initial PCR step, heating to 95℃, was sufficient to lyse blood cells and liberate their genomic DNA contents; therefore, the target DNA fragments were efficiently amplified (Fig. 2) .
PCR performed directly on whole blood is a more rapid and simple approach because DNA purification is both time- Several direct PCR protocols that do not require DNA isolation have been developed. The simple pretreatment of whole blood with heat [21] , microwave [22] , or formamide [23] has been attempted for direct PCR amplification of the target DNA. Unfortunately, these methods failed to generate successful results, and significant variations were observed in the data obtained. Recently, Ampdirect solution (Shimadzu, Kyoto, Japan) was developed and used to amplify the target DNA from human whole blood [24] . However, this solution was ineffective when used with chemically modified Taq DNA polymerases [24] . In contrast, AnyDirect solution was used successfully for direct amplification from low copy number DNA in whole blood with chemically modified hot-start Taq DNA polymerase [17] .
Specificity and sensitivity are particularly crucial for diagnostic applications when the target is in poor quality, as occurs in whole blood. The specificity and sensitivity of direct PCR using AnyDirect solution was previously compared using purified genomic DNA and whole blood as templates [17] . The specificity of direct PCR using AnyDirect solution was demonstrated by detecting variably sized tar-ABO Genotyping Using Whole Blood Without DNA Purificationget DNA sequences of the p53 gene from whole blood without isolation of the DNA. Amplification of fragments of the p53 gene that ranged from 146 bp to 1,702 bp from purified human genomic DNA using conventional PCR reaction buffer produced weak and smeared bands or nonspecific bands.
However, a single PCR product of the expected size was amplified from whole blood samples in the presence of AnyDirect solution [17] .
The sensitivity of direct PCR using AnyDirect solution was determined by testing the decreasing copy number of a plasmid containing the HIV-1 genome. Using AnyDirect solution, low copy number DNA targets were effectively amplified from whole blood, and the sensitivity of detection was determined by obtaining a positive amplification signal using 10 copies of HIV-1 plasmid in 1 μ L whole blood as the PCR template [17] . The specificity and sensitivity of our multiplex ASPCR assay was also confirmed by simultaneous detection of all three PCR products from 1.5 μ L whole blood samples in a single reaction tube (Fig. 2 ).
In conclusion, this new multiplex ASPCR assay performed on whole blood is a rapid, simple, and convenient test. In addition, this fast and accurate technique offers a supplement to routine serological ABO typing results, and might also be useful in forensic applications. 
